Your browser doesn't support javascript.
loading
Shikonin is a novel and selective IMPDH2 inhibitor that target triple-negative breast cancer.
Wang, Wanyan; Wu, Yu; Chen, Si; Liu, Xi; He, Jiacheng; Wang, Shuyi; Lu, Weiqiang; Tang, Yong; Huang, Jin.
Afiliação
  • Wang W; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
  • Wu Y; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
  • Chen S; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Liu X; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
  • He J; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Wang S; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Lu W; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
  • Tang Y; Department of Urology, Wuming Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Huang J; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
Phytother Res ; 35(1): 463-476, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32779300
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Naftoquinonas / Inibidores Enzimáticos / Neoplasias de Mama Triplo Negativas / IMP Desidrogenase Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Phytother Res Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Naftoquinonas / Inibidores Enzimáticos / Neoplasias de Mama Triplo Negativas / IMP Desidrogenase Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Phytother Res Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido